Short Interest Remains Mixed for Major Biotechs

Health and Healthcare

Published: January 13, 2016 8:35 am

Last Updated: January 13, 2020 3:06 pm

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.

The December 31 short interest data have been compared with the previous report, and short interest continued to be mixed in these selected stocks for this settlement date.

Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 8.88 million shares from the previous level of 8.35 million. Shares closed most recently at $150.79, in a 52-week trading range of $130.09 to $181.81.

Biogen Inc. (NASDAQ: BIIB) had its short interest remain flat at 2.57 million. Shares closed most recently at $278.67, within a 52-week range of $254.00 to $480.18.

Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 8.32 million shares from the previous 9.20 million. Shares of Celgene closed most recently at $106.85, in a 52-week range of $92.98 to $140.72.

24/7 Wall St.
The 6 Most Shorted Nasdaq Stocks: Short Sellers Give Up on Intel, Apple

Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest fall to 23.73 million shares from 25.25 million in the previous period. Shares closed most recently at $97.10, in a 52-week trading range of $86.00 to $123.37.

MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 120.72 million shares. The previous reading was 111.52 million. Shares closed most recently at $0.77, in a 52-week trading range of $0.64 to $7.88.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased to 5.86 million, compared to the previous level of 5.97 million. Shares closed most recently at $166.12, in a 52-week range of $142.02 to $208.88.

Take Charge of Your Retirement In Just A Few Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.

Here’s how it works:

Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
Choose Your Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!